Levine Leichtman partner Mike Weinberg talks investing in pharma services; KKR closes 13th flagship on $19bn
KKR racks up $19 billion for newest fund.
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group .-
Sign in or Register
-
Issues with signing in? Click here
Don't have an account? Register now
-
